As of March 2015, TM Capital has relocated our Boston office to the 32nd floor of One Boston Place.

See the Winning Photos and Charitable Donations from TM Capital’s 2014 Contest: Where in the World is the TM Blanket?

Andy Krna has been named Vice President. Andy joined TM Capital’s New York office in 2012 and has made countless contributions, taking part in C.B. Fleet’s acquisition by Gryphon, SeaWorld’s Repurchase of Common Stock and many other notable transactions.

2014, TM Capital’s 25th anniversary year, has been a remarkable success in so many ways. As we reflect on our good fortune during this Holiday Season, we thank you for your friendship and support. Most importantly, we wish you and your family a New Year overflowing with health, happiness and peace.

TM Capital served as exclusive financial advisor to C.B. Fleet Company, Inc. (“Fleet Laboratories”) – a leading manufacturer and marketer of consumer branded, OTC health and personal care products – in its sale to Gryphon Investors, a San Francisco-based private equity firm. Family owned for 145 years, the Company’s brands are trusted market leaders across key consumer categories.

Lawyer Monthly features TM Capital’s transaction, Sapheon acquired by Covidien.

TM Capital’s role in the Recapitalization of Tate’s Bake Shop with The Riverside Company is featured in Newsday. See the full article here.

TM Capital served as exclusive financial advisor to Tate’s Bake Shop, a leading marketer of premium branded baked goods, in its recapitalization with The Riverside Company, a global private equity firm with more than $4.6 billion of capital under management. TM assisted Tate’s founder, Kathleen King, in attracting a partner that shares her vision and offers the resources necessary to capitalize on the company’s numerous growth opportunities.

TM Capital served as exclusive advisor to Sapheon Inc., a privately held developer of an innovative venous disease treatment, in its sale to Covidien plc, a global leader in the treatment of peripheral vascular disease. This is the latest in a series of notable assignments in which the principals of TM Capital have assisted growing companies with novel technologies in achieving superior valuations from the world’s largest strategic healthcare acquirers.

TM Capital’s Tech-Enabled Services team is off to a torrid start in 2014, completing three sell-side transactions in the past two months spanning the breadth of our TES expertise. Ranging from business process outsourcing (BPO) to outsourced product development (OPD) and IT infrastructure consulting, these deals represent the diversity of the transaction capabilities our team artfully delivers, including cross-border acquisitions, public company corporate divestitures and founder-owned, family-led private sales.